- Joined Pharmetheus in 2016, actively working in client projects, leading the Client Operations Forum, and as Project Portfolio Team Leader managing a team of MIDD consultants.
- Expertise includes pharmacometrics, submission, pediatric investigation plans, and MIDD support in therapeutic areas such as oncology and metabolism disorders.
- Experience as Senior Consultant at SGS-Exprimo, Belgium, where she delivered modeling results to support submissions and internal decisions. Previously, she worked as Senior Expert Modeler at Novartis, Switzerland, Cluster Leader at Novartis, USA, and Modeler at Novartis, Switzerland.
- Pharm.D. (2004) from University Paris XII, France, and Ph.D. in Pharmaceutical Biosciences (2006) from University Lyon Claude Bernard, France.
Pharmetheus affiliated publications
A framework for prediction of progression free survival based on modelling of sub-endpointsApplication of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II studyPopulation PK analysis of Pegaspargase in Japanese and non-Japanese patients with acute lymphoblastic leukemiaHow to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an ExampleExposure–Safety Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung DiseaseThe Standard Output: A Tool-Agnostic Modeling Storage FormatPopulation PK and PASI Exposure-Response Modelling for Certolizumab Pegol in Patients with Chronic Plaque PsoriasisOpen Innovation: Towards Sharing of Data, Models and Workflows